Followers | 123 |
Posts | 16653 |
Boards Moderated | 1 |
Alias Born | 07/21/2006 |
Tuesday, February 09, 2021 12:22:50 PM
Recent ZYME News
- Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/02/2024 08:05:00 PM
- Zymeworks Announces Participation in Upcoming Investor Conferences • GlobeNewswire Inc. • 04/30/2024 10:00:00 AM
- Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024 • GlobeNewswire Inc. • 04/11/2024 10:00:00 AM
- Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting • GlobeNewswire Inc. • 04/08/2024 10:00:00 AM
- Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors • GlobeNewswire Inc. • 03/28/2024 10:00:00 AM
- Zymeworks Announces Participation in Upcoming Investor Conferences • GlobeNewswire Inc. • 03/27/2024 10:00:00 AM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 03/07/2024 09:46:26 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 03/07/2024 09:36:50 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/06/2024 10:25:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:13:25 PM
- Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/06/2024 09:09:10 PM
- Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual Meeting • GlobeNewswire Inc. • 03/05/2024 09:30:00 PM
- Zymeworks Announces Participation in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/27/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 09:15:49 PM
- Zymeworks To Host Fourth Quarter and Full Year 2023 Results Conference Call • GlobeNewswire Inc. • 02/14/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:16:59 PM
- Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors • GlobeNewswire Inc. • 02/08/2024 11:00:00 AM
- Zymeworks Announces Participation in Upcoming Investor Conferences • GlobeNewswire Inc. • 01/31/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 11:01:26 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/06/2024 02:44:49 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 12:00:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 11:31:00 AM
- Zymeworks Outlines Strategic Priorities and Outlook for 2024 and 2025 • GlobeNewswire Inc. • 01/04/2024 11:15:00 AM
- Zymeworks Announces Additional Leadership Appointments • GlobeNewswire Inc. • 01/04/2024 11:00:00 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM